n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, July 14th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

MediXall Group, Inc. (MDXL)

MarketWatch and TradingView reported on MediXall Group, Inc. (MDXL), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

MediXall Group, Inc. is a technology and innovation-driven organization structured to bring effective change to the U.S. healthcare industry. The Company’s mission is to revolutionize the medical industry through improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. MediXall is the beneficiary of 12 patents and 20 pending patents in the healthcare technology industry. MediXall Group is headquartered in Ft. Lauderdale, Florida.

MediXall’s initial acquisition was MediXaid™. This is a developing cloud-based software platform. It is centering on transforming the way people purchase healthcare goods and services.

The MediXaid platform provides a B2C (Business-to-Consumer) capability. It brings together into a single cloud-based, patent-pending virtual marketplace the consumers of healthcare products and services with providers that compete on price, location, and schedule for requested products and services.

The MediXaid platform will give providers the opportunity to reach a higher percentage of self-pay and high-deductible consumers. This can significantly benefit the providers' practice and assure higher cash flow through instant payment for services. Consumers benefit by having greater access to more affordable qualified services in their immediate area with more transparency in the pricing among providers.

All providers of products and services on the MediXaid platform will be required to participate in a basic credentialing review. This would include review of State-issued professional and occupational licenses; Medicare Medicaid NPI (National Provider Identifier); National Practitioner Data Bank and third-party certification such as NCQA, JTC, HFAP, AAACA or others approved by MediXall Group.

Recently, MediXall Group announced that it will offer financial products to its MediXaid® platform members, to help them in developing their businesses and client/patient relationships. The financing products will include plans to serve the health care providers, and their patients, with loans to cover business expansion, equipment purchases and leases, and also patient procedures.

Last week, MediXall Group announced that via its program to recruit and enlist licensed and certified Diagnostic Centers, medical service, medical product providers, and Physician Practices to its Member Network, more than 1,000 healthcare providers have opted-in. These healthcare providers, through opting in, have taken the first step into joining MediXaid and becoming an "Early Adopter" in the ground-breaking MediXaid Provider Network. 

MediXall Group, Inc. (MDXL), closed Friday's trading session at $2.33, up 2.19%, on 100 volume with 1 trade. The average volume for the last 60 days is 325 and the stock's 52-week low/high is $0.75/$3.90.

Stony Hill Corp. (STNY)

OTC Markets, MarketWatch, Bloomberg, Wall Street Journal, and Market Exclusive reported on Stony Hill Corp. (STNY), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Stony Hill Corp. is a diversified enterprise centered on numerous areas of the cannabis, hemp, and CBD industry. The Company’s emphasis is on select investment, branding, real estate, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries. Listed on the OTCQB, Stony Hill is headquartered in Beverly Hills, California.

Damian Marley founded Stony Hill. The Company has a number of strategic partnerships now in place. It is actively pursuing additional partnerships and other strategic growth opportunities. Its partners include Ocean Grown Extracts, VitaCBD, and High Times.

In February of this year, Stony Hill announced that it entered into an asset purchase agreement with mCig., Inc. (MCIG). The parties entered into an asset purchase agreement for pursuing mutually beneficial business opportunities in the Cannabidiol (CBD) Industry. With this agreement, mCig sold the VitaCBD brand to Stony Hill in exchange for total consideration of $850,000 in cash and common stock, as well as a 20 percent stake in VitaCBD, LLC, a subsidiary of Stony Hill.

In March, Stony Hill announced that it made a strategic investment in Cannabi-Tech Ltd. The Company acquired the stake in Cannabi-Tech as part of a larger effort to build an international platform and brand for Cannabi-Tech. Cannabi-Tech is a provider of lab-grade medical cannabis quality control testing systems based in Israel. Its proprietary technology features pioneering optical and image processing tools for precise quality control testing of medical marijuana flowers.

Last month, Stony Hill announced that it made a strategic investment in High Times Holding Corp. With this agreement, Stony Hill will make a direct equity investment into High Times Holding. Stony Hill will be a passive investor. However, the Company said that it looks forward to an expanding relationship with High Times with additional strategic partnership opportunities in the future.

High Times has been the authoritative voice of authentic cannabis culture for over 40 years. This includes leading the battle for legalization and empowering entrepreneurs in this expanding industry.

Mr. Adam Levin, High Times Holdings’ Chief Executive Officer, stated, "We are pleased to welcome Stony Hill and Damian Marley as a long-term investor and strategic partner. Stony Hill has a broad portfolio of products and assets which we believe will make it a strong partner and ally. We believe the mutually beneficial relationship will develop new opportunities for both our companies."

Stony Hill Corp. (STNY), closed Friday's trading session at $2.40, down 4.00%, on 400 volume with 3 trades. The average volume for the last 60 days is 893 and the stock's 52-week low/high is $0.60/$5.00.

Acura Pharmaceuticals, Inc. (ACUR)

StreetInsider, Marketbeat.com, BUYINS.NET, SmarTrend Newsletters, Wall Street Resources, The Street, PennyStocks24, Penny Stock Rumble, BestOtc, CRWEFinance, CRWEWallStreet, PennyOmega, PennyToBuck, StockHotTips, and DrStockPick reported earlier on Acura Pharmaceuticals, Inc. (ACUR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company innovating abuse deterrent drugs. The Company involves in the research, development, and commercialization of product candidates intended to address medication abuse and misuse, employing its proprietary LIMITx™, AVERSION® and IMPEDE® Technologies. Acura Pharmaceuticals is based in Palatine, Illinois, and its shares trade on the OTCQB.

The intention of the Company’s LIMITX™ Technology is to address an oral Excessive Tablet Abuse (ETA) or accidental consumption of multiple tablets, as well as provide a margin of safety during accidental over-ingestion of tablets. In addition, LIMITX™ is expected to exhibit barriers to abuse by snorting and injection. LTX-04 is Acura Pharmaceuticals’ lead development candidate utilizing its novel LIMITx™ technology.

AVERSION® Technology is a patented composition of commonly used active and inactive pharmaceutical ingredients providing abuse deterrent features and benefits for orally administered pharmaceutical drug products. The intention of AVERSION® Technology opioid analgesic product candidates is to provide effective relief from pain. This is while discouraging common methods of pharmaceutical product misuse and abuse.

The IMPEDE® Technology platform is an advanced polymer matrix. It is utilized in NEXAFED®, the Company’s pseudoephedrine (PSE) tablet product, to limit or disrupt the extraction of PSE from tablets for conversion into the illicit drug methamphetamine.

OXAYDO® (oxycodone HCl immediate-release tablets) that incorporates the AVERSION Technology, is Food and Drug Administration (FDA) approved and marketed in the United States by Acura’s partner Egalet Corp. NEXAFED® and NEXAFED® Sinus are pseudoephedrine containing products that utilize the IMPEDE Technology. They are marketed in the United States by Acura’s partner MainPointe Pharmaceuticals.

Recently, Acura Pharmaceuticals announced that it completed enrollment and initiated dosing in a second Phase 1 human pharmacokinetic trial of LTX-04.  The patented LIMITx technology works through neutralizing stomach acid as increasing numbers of tablets are swallowed and relying on stomach acid to play a role in the release and subsequent systemic absorption of the active ingredient from micro-particles contained in the tablets.

In late June, Acura Pharmaceuticals announced the results from its second clinical study, study AP-LTX-401 (Study 401).  Study 401, when considered with the results of its first clinical study (Study AP-LTX-400 or Study 400) demonstrate that the maximum plasma level of drug (Cmax) following oral excessive tablet abuse (Oral ETA dosing levels are in excess of 2 tablets at a time) of the early development stage product LTX-04P3 are lessened by up to 65 percent versus presently marketed products.

The single tablet dose of LTX-04P3 in Study 401 achieved a Cmax, which was 52 percent of the Cmax of the marketed comparator. This indicates that the present LTX-04 formulation contains excess buffering ingredients resulting in incomplete release of drug.

Acura Pharmaceuticals is developing plans for a buffer dose ranging study to guide the reformulation of the tablet buffers to increase the single dose Cmax, while retaining a decrease in Cmax in multiple LIMITx tablets. A change in development emphasis is planned from LTX-04, an immediate-release hydromorphone product, to LTX-03, an immediate-release hydrocodone bitartrate product, in subsequent studies. Hydrocodone bitartrate is more apt to be abused by Oral ETA.

Acura Pharmaceuticals, Inc. (ACUR), closed Friday's trading session at $0.511764, up 0.33%, on 2,368 volume with 6 trades. The average volume for the last 60 days is 12,959 and the stock's 52-week low/high is $0.401/$2.18.

TurnKey Capital, Inc. (TKCI)

InvestorsHub, MarketWatch, and TradingView reported on TurnKey Capital, Inc. (TKCI), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

TurnKey Capital, Inc. aligns with and builds value in private, public, and development-stage companies. It works to identify opportunities in high-growth sectors, with an initial emphasis on the developing cannabis industry. The Company previously went by the name Train Travel Holdings, Inc. It changed its name to TurnKey Capital, Inc. in February of 2016. A business advisory company, TurnKey Capital is based in Fort Lauderdale, Florida.

Turnkey Capital provides a broad assortment of services. These include equity and debt financing for growth, strategic operational and management resources, and financial advice, modeling, and long term corporate and shareholder support. It engages companies that have missing elements within the financials and operations of their company. These missing elements restrict companies’ ability to expand.

Turnkey Capital establishes value for company shareholders through securing debt and equity positions in select companies. Consequently, the Company builds a group of undervalued businesses that it will work to increase in value. As a result, this enables TurnKey Capital shareholders to benefit from enhanced value alongside client companies.

Turnkey Capital announced in January 2017 that it executed a Letter of Intent (LOI) with Brand Strategy Group International. This is to engage in brand license and management within a wide spectrum of categories. TurnKey Capital has identified Brand Strategy Group, Inc. (BSGI) as its initial potential licensing partner. Brand Strategy Group owns all intellectual property (IP), licenses, trademarks, and trade names associated with the men's fashion brand, Phillip Acker™. The Phillip Acker™ brand is contemporary streetwear.

Important necessities of TurnKey Capital are capital structure and shareholder relations. Basically, the Company approaches venture-capital from a financial viewpoint.

This week, Turnkey Capital announced that it signed a strategic alliance agreement with Seminole Indian Company. This agreement is to provide business formation, development, and financial infrastructure services to unique opportunities afforded by tribal sovereignty.

Leading the Seminole Indian Company team is former Seminole Tribal Chairman, Mr. James E. Billie.  "Chief Billie" is the Tribe's long-time leader. Mr. Billie is credited with kindling the $33 billion Indian gambling industry. This includes the renowned Hard Rock Hotels and Casinos in Hollywood and Tampa, Florida. Chief Billie and his partner, Mr. Craig Talesman, have recently created relationships with industry leaders in the developing cannabis industry.

Mr. Neil Swartz, Chief Executive Officer of TurnKey Capital, stated, "Over the past year we have expanded the scope of our operations beyond the real estate industry to include team members with decades of experience in procuring capital for the development and expansion of emerging companies, and have been serving as business advisors and facilitators to client companies that are ready to grow or go public. Chief Billie's stellar track record in creating American Indian companies, and his relationships in unique markets such as entertainment and cannabis, indicate that this alliance will have tremendous potential." 

TurnKey Capital, Inc. (TKCI), closed Friday's trading session at $0.149, up 49.00%, on 86,200 volume with 24 trades. The average volume for the last 60 days is 13,889 and the stock's 52-week low/high is $0.02/$0.25.

Cosmos Holdings, Inc. (COSM)

TopPennyStockMovers and OTC Markets Group reported earlier on Cosmos Holdings, Inc. (COSM), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Cosmos Holdings, Inc. is a fully reporting International Holding company headquartered in Chicago, Illinois. It conducts its business within the pharmaceutical industry. The Company’s concentration is on identifying, acquiring, developing, and commercializing medicines to improve patients' lives and outcomes. Cosmos has its wholly-owned subsidiary, SkyPharm. Sky Pharm trades the excess amounts of approximately 500 medicines, which can be exported within the European Union (EU) countries. OTCQB-listed, Cosmos Holdings has its warehouse and distribution center in Thessaloniki, Greece.

Cosmos Holdings is presently focusing its existing operations on expanding the business of SkyPharm S.A. The Company has focused its efforts on becoming a global pharmaceutical enterprise. Its emphasis will be on Branded Pharmaceuticals, Over-the-Counter (OTC) medicines, Generic Pharmaceuticals, Cosmetics Products & Food Supplements, Research & Development (R&D), and Growth Opportunities.

Cosmos looks to continue to enhance its pharmaceutical and OTC product lines through acquiring or licensing rights to additional products. The Company also looks to regularly evaluate selective acquisition and license opportunities. Cosmos has a trans-European network of over 60 clients and vendors in Germany, the United Kingdom, Ireland, Denmark, Poland, Netherlands, and Greece.

Cosmos’ dedication is to pursue diverse kinds of business development. It states that this can include trading, alliances, licenses, joint ventures (JVs), dispositions and acquisitions. Additionally, the Company hopes to continue to build on its portfolio of pharmaceutical products and expand its product pipeline to generic and cosmetics products.

In February 2017, Cosmos Holdings announced that it acquired 100 percent of the shares of Decahedron Ltd.  Decahedron is a privately held company located in Harlow, United Kingdom. Decahedron is a pharmaceutical wholesaler that imports and exports branded, generic, and unlicensed medicines, OTCs (Over-the-Counters) and Medical devices in numerous countries. In addition, it participates in governmental tenders and registering. Decahedron’s network comprises greater than 25 clients and vendors expanding to nine countries. These include Germany, the UK, Denmark, United Arab Emirates (UAE), Germany, Italy, France, Singapore, and Ireland.

Recently, Cosmos Holdings announced that it signed a new Letter of Intent (LOI) to acquire the outstanding shares of CC Pharma GmbH. With this LOI, Cosmos Holdings holds the exclusive right to complete its due diligence process and complete the transaction by October 31, 2017. CC Pharma GmbH (based in Densborn, Germany) is a foremost re-importer of EU pharmaceuticals to Germany.

Furthermore, under the terms of the LOI, the parties agreed that certain current managers of CC Pharma GmbH will remain with Cosmos Holdings until at least December 31, 2018. CC Pharma covers the whole value chain. Its core business centers on registration, repackaging, and delivery of high‐priced pharmaceuticals to wholesale customers and pharmacies.

Cosmos Holdings, Inc. (COSM), closed Friday's trading session at $0.655, down 0.76%, on 8,700 volume with 9 trades. The average volume for the last 60 days is 10,480 and the stock's 52-week low/high is $0.351/$0.94.

graphic

The QualityStocks
Company Corner

graphic
graphic

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $0.804, off by 0.74%, on 20,377 volume with 34 trades. The stock’s average daily volume over the past 60 days is 51,672 and its 52-week low/high is $0.12/$2.75.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ChineseInvestors.com, Inc. (OTCQB: CIIX), a client of NNW recognizing unprecedented opportunities in the U.S. cannabis industry and laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products. The publication, entitled, "Savvy Publicly Traded Bitcoin Players Contributing to Cryptocurrency's Widespread Adoption," describes how various publicly traded companies are rushing to profit from the growing acceptance of bitcoin. To view the full publication, visit: https://www.networknewswire.com/savvy-publicly-traded-bitcoin-players-contributing-cryptocurrencys-widespread-adoption/

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com Blog

ChineseInvestors.com News:

NetworkNewsWire Announces Publication that Highlights Several Public Companies, Including ChineseInvestors.com, Inc. (OTCQB: CIIX), Which Are Taking Advantage of the Mounting Acceptance of Digital Currency

ChineseInvestors.com, Inc. Announces its Wholly-owned Subsidiary, Chinesehempoil.com Inc., Will Officially Accept Bitcoin Payments

CFN Media Interviews ChineseInvestors.com CEO Warren Wang

Converde Energy USA, Inc. (XFUL)

The QualityStocks Daily Newsletter would like to spotlight Converde Energy USA, Inc. (XFUL). Today, Converde Energy USA, Inc. closed trading at $0.0042, up 35.48%, on 214,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 1,509,332, and its 52-week low/high is $0.0002/$0.10.

Converde Energy USA, Inc. (XFUL), d/b/a American Energy Partners Inc., and its group of companies are dedicated to delivering solutions wherever energy production and water meet technology. The company has positioned itself to benefit from above-favorable margins on each of its subsidiaries due to the synergy of the chain of revenues.

Hydration Company of PA (HCPA)
Hydration Company of PA focuses on sourcing, implementing and distributing reclaimed water at a profit. This subsidiary's competitive advantage mainly lies within its pure volume of reclaimed water and its access to low cost treatment with high flow rates and highly concentrated solids through the technologies of XFUL's partners. Because of the volume as well as the flexibility of the model established via patent pending methodology and conveyance methods, HCPA can effectively gain market share immediately as large corporations prefer access to one source that can supply massive amounts of reclaimed water regardless of drought conditions.

American Energy Solutions, LLC
American Energy Solutions, LLC utilizes a network of partners to provide off-the-shelf and custom-designed treatment technologies that contribute to HCPA's business model of low-cost treatment and distribution. As a provider of design, this subsidiary is capable of repeatable and synergistic services across the value chain. American Energy's long-term plan is to utilize an in-house team to grow market share as water use continues to become more critical to modern industry.

Gilbert Oil & Gas Company
Gilbert Oil & Gas Company is leveraging broad industry valuation experience to move forward on its mission to add shareholder value through drilling, operating, and partnership opportunities in the upstream oil and gas space. Equipped with the in-house capabilities necessary to source and evaluate opportunities for profitability, Gilbert is positioned to become a strong customer of XFUL's other subsidiaries, providing them with the foundation to attract other customers and enter new markets.

Integrated Business Strategy
By combining ownership of water sources via Hydration Company of PA, design and treatment solutions via American Energy Solutions, and a stream of promising opportunities via Gilbert Oil & Gas Company, XFUL is essentially creating a positive revenue feedback loop. This synergistic business model also opens opportunity for higher profit margins, additional revenue, and faster growth in new markets. Disclaimer

Converde Energy USA, Inc. Company Blog

Converde Energy USA, Inc. News:

NetworkNewsBreaks – American Energy Partners, Inc. (XFUL) Featured in Exclusive Audio Interview by NetworkNewsWire

Converde Energy USA, Inc. Appoints Josh Hickman, President of Subsidiary's O&G Operations and to Board of Directors

American Energy Partners, Inc. (XFUL) d/b/a Converde Energy USA, Inc. Engages NetworkNewsWire for Corporate Communications Solutions

Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ). Today, Epazz, Inc. closed trading at $0.012, up 20.00%, on 6,500 volume with 2 trades. The stock’s average daily volume over the past 60 days is 77,933, and its 52-week low/high is $0.0061/$0.09.

Epazz, Inc. (EPAZ), is an enterprise-wide software company specializing in customized web applications for higher education institutions and the public sector. Through its proprietary BoxesOS applications, the company aims to create and maintain virtual communities that facilitate enhanced communication and provide up-to-date information and content in order to streamline the decision-making process for its clients. Epazz's BoxesOS also serves as a secure digital marketplace for various types of commerce, allowing the company to meet the increasing information technology demands of the 21st century.

In addition to its BoxesOS administrative services, Epazz offers a full end-user suite of solutions designed to maximize communication and functionality with full-featured web-based intranet software. Leveraging these offerings, the company's clients gain secure access and administrative control to customized features based on their unique needs. For businesses, the value of implementing these services can be tremendous. According to data from the McKinsey Global Institute, productivity improves by as much as 25 percent in organizations with connected employees. Studying just four commercial sectors (consumer packaged goods, retail financial services, advanced manufacturing and professional services), McKinsey estimates that the fiscal contributions of implementing effective intranet solutions could amount to as much as $1.3 trillion annually.

BoxesOS also allows companies to enhance communications with stakeholders by providing one-stop access to elegant, web-enabled information dashboards designed for specific user groups. Offering the ability to create unique dashboards for each stakeholder group addresses one of the most prominent issues facing workplace intranet projects – lack of engagement. Industry data suggest that properly engaging three core types of stakeholders, including executives, implementers and users, as well as the many sub-types within each of those groups, is key to the successful implementation of digital workplace solutions.

Outside of its business software solutions, Epazz is currently addressing a rising demand in the legal cannabis industry through its ZenaPay payment system. While banks remain hesitant regarding the legality of state-approved cannabis programs, dispensaries and related businesses have been compelled to operate on a cash-only basis, creating both security concerns and inconvenience for their customers. With ZenaPay, Epazz seeks to eliminate this issue by relying on the widely-used bitcoin cryptocurrency to provide an alternative to cash transactions. These efforts are particularly intriguing when studying the forward projections associated with marijuana sales. Per ArcView Market Research, North American marijuana sales grew by an unprecedented 30 percent in 2016 to $6.7 billion, and this figure is expected to top $20.2 billion by 2021.

Epazz is led by founder, chairman and CEO Shaun Passley, Ph.D. Founding the company in February 1999, Passley has been the guiding force behind Epazz's software and product development, as well as its continuing development of future products and services. Passley is joined on the Epazz management team by Raymond Kennedy, director of sales. Kennedy has more than two decades of experience in enterprise software sales, having previously served as marketing director for HCM, Inc., where he established six new sales territories and increased overall sales by more than 30 percent. Disclaimer

Epazz, Inc. Company Blog

Epazz, Inc. News:

Epazz, Inc. Featured on MoneyTV with Donald Baillargeon, 6/2

Epazz, Inc. Reports Increase First Quarter Revenue and Profitability; Company is Focusing on Improving Fundamentals; Increasing Sales, Reducing Operational Expenses and Increasing Income

Epazz, Inc. Launches Zenapay.com, the Company's New Cannabis Payment System

Patriot One Technologies, Inc. (PTOTF)

The QualityStocks Daily Newsletter would like to spotlight Patriot One Technologies, Inc. (PTOTF). Today, Patriot One Technologies, Inc. closed trading at $0.6109, up 2.86%, on 29,156 volume with 19 trades. The stock’s average daily volume over the past 60 days is 81,848, and its 52-week low/high is $0.4665/$1.49.

Patriot One Technologies, Inc. (PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology.

Developed through a NATO-funded project at McMaster University, Patriot One's disruptive NForce CMR1000 technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide.

A recent study that surveyed data going back as far as 1966 demonstrates that there have been significantly more mass shootings in the U.S. than any other country for decades. Statistics for the 46-year period shows that even though America only holds 5% of the world's population, it took count of 31% of all public mass shootings. According to the FBI, there were an astounding 160 incidents from 2000 to 2013 that resulted in 486 people killed and 557 wounded. In years 2014 and 2015, there were nearly six times as many incidents compared to 2000 and 2001. The disturbing trend shows that there will be increasingly more incidents if better preventative measures aren't taken.

Patriot One's patent-pending solution to this alarming progression enables stand-off detection, even on moving targets, with a "cognitive" ability to learn and identify new threats once deployed. The product is not intended to threaten the constitutional rights of legal gun carriers, and it is also void of privacy and health concerns of traditional detection technologies, which require subject compliance, present false positives, and are often slow, inefficient and costly.

In contrast, Patriot One's technology is small in size and can be "covertly" placed in a doorway or hallway to prevent planned attacks in public places like schools, concerts, stadiums, banks, airports, offices, hospitals, shopping centers and other facilities for which there are concerns. With this method of deployment, there is no subject compliance requirement. In addition, because an image of the target is not generated, there are also no privacy concerns. Detection is real-time and entirely computer-based, which means there is no need for human operators to alert security. This eliminates the safety concerns of a would-be operator, reduces the expense of a human operator, and enables overall accuracy of 93%.

The technology is designed to identify if someone is carrying a gun, knife, suicide vest, etc., by analyzing metal content and relating it to a database of known weapon signatures. Patriot One believes the widespread use of this detection technology could act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the nation and around the world.

The company is guided by a team of experts in the areas of high-frequency electromagnetics, counter-terrorism, conflict resolution, government/corporate interface, sensor development, proactive security and business development. Senior Management has partnered with, among other affiliates, Ridge Global, which was founded by recently appointed advisory board member Tom Ridge, the first head of the Department of Homeland Security, first U.S. Secretary of Homeland Security, and 43rd governor of Pennsylvania.

Along with its partners, Patriot One is addressing global concerns of active shooting events and other violent terrorist attacks. The key is to short-circuit the event through effective prevention technologies and security protocols. Disclaimer

Patriot One Technologies, Inc. Company Blog

Patriot One Technologies, Inc. News:

Patriot One Initiates Pacific Rim Sales with Aotea Security of New Zealand

Patriot One Marks 3-Months of Global PATSCAN Sales with $2.7M in Signed Agreements

Patriot One Appoints Former Senior Counter Terrorism Official John Gillies to Board

BlastGard International Inc. (BLGA)

The QualityStocks Daily Newsletter would like to spotlight BlastGard International Inc. (BLGA). Today, BlastGard International Inc. closed trading at $0.0181, off by 7.12%, on 10,188 volume with 3 trades. The stock’s average daily volume over the past 60 days is 115,858 and its 52-week low/high is $0.005/$0.03.

BlastGard International Inc. (BLGA) is a manufacturer and distributor of protective products for military and law enforcement personnel. The Corporation operates under two segments, BlastGard Defense Group and Highcom Security.

Blastguard is a blast mitigation specialist with proprietary material proven to effectively mitigate blasts and suppress fires resulting from explosions. The company's patented BlastWrap® technology acts as a "virtual tent" to effectively mitigate blast effects and suppress post-blast fires. This unique technology works by triggering physical and chemical processes to dissipate blast energy, thereby reducing the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, significantly reduced energy is transmitted at a slower, more sustainable level. Notably, BlastWrap does not dispense chemical extinguishants; uses neither alarms, sensors, nor an activation system; and is nontoxic and ecologically friendly.

Similarly, the company's BlastGard MTR trash receptacles dramatically reduce lethal threats posed by the detonation of an improvised explosive device (IED). Equipped with Triple Wall Technology, BlastGard MTR mitigates primary fragments, secondary fragments, mechanical effects (shock/blast pressure) and thermal effects (contact and radiation burn) from the fireball, after-burn and resultant post-blast fires.

BlastGard's primary market focus lies on providing blast effects mitigation solutions for customers operating in the commercial sector, military, law enforcement and government agencies. With a vision of being recognized as the leading provider of environmentally responsible solutions to protect lives and structures from the hazards associated with fire and explosions, the company is capable of addressing a wide array of industry applications spanning from fire suppression for naval vessels and merchant ships to protection of buildings against vehicle bombs.

This vision is supported by the ban of Halon extinguishing agents, as outlined in the Montreal protocol, which effectively establishes BlastWrap® as the only blast and fire suppression means available for most applications, including adaptation for underwater use.

The company's position at the head of the blast suppression market has helped BlastGard attain a number of government awards, including designation of its BlastWrap® product as a Qualified Anti-Terrorism Technology and placement on the "Approved Products List for Homeland Security." This designation was extended in early 2017, meaning that BlastWrap® is approved for use by the Department of Homeland Security under the SAFETY Act until November 2021.

HighCom Security, develops, tests, manufactures and distributes body armor and personal protective equipment, including more than two dozen NIJ (National Institute of Justice) compliant hard and soft armor products. Highcom Security has a 20-year history of producing quality armor with no operational failures and no recalls of its American made products.

Highcom Security was founded in 1997 and has produced close to 1 million pieces of armor for the Global community. The company is ISO 9001:2008 certified and the first company in the world to be BA 9000:2012 certified compliant.

For the past decade, Highcom Security has also been able to offer some of the largest armor manufacturers with private label/OEM hard armor solutions for end use by military and law enforcement agencies globally, a market reach obtained because of the company's reputation for innovative technology, exceptional customer service and superior quality performance. Disclaimer

BlastGard International Inc. Blog

BlastGard International Inc. News:

BlastGard International, Inc. (BLGA) Engages NetworkNewsWire for Corporate Communications Solutions

BlastGard International Inc. (BLGA) is “One to Watch”

BlastGard International Addresses Company's Trading Activity

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Stock Commander
(ICNN) +160.08%

2.

QualityStocks
(TKCI) +49.00%

3.

NetworkNewsWire
(XFUL) +35.48%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251